Mega%252525252525252525252525252525252520cv

# Mega CV (Amoxicillin/Clavulanate) ## Overview Mega CV is a combination antibiotic consisting of amoxicillin (a beta-lactam penicillin) and clavulanate potassium (a beta-lactamase inhibitor). The clavulanate component expands the spectrum of activity against beta-lactamase-producing bacteria that are resistant to amoxicillin alone. ## Primary Indications Commonly used for bacterial infections, including: * Acute bacterial rhinosinusitis. * Community-acquired pneumonia. * Otitis media. * Skin and skin structure infections. * Urinary tract infections (less common, usually second-line). ## Adult Dosing Standard dosing is typically expressed in terms of the amoxicillin component: * **Mild to Moderate Infections:** 500 mg amoxicillin/125 mg clavulanate PO every 8–12 hours. * **Severe Infections / Respiratory Tract Infections:** 875 mg amoxicillin/125 mg clavulanate PO every 12 hours. * Do not use the 875 mg tablet in patients with severe renal impairment. ## Pediatric Dosing Based on the amoxicillin component, usually 20–45 mg/kg/day in divided doses. * **Otitis Media/Severe Infections:** 90 mg/kg/day divided every 12 hours (using the 7:1 or 14:1 ratio formulations). * **Maximum:** Do not exceed adult doses. * *Note: Always verify the concentration of the suspension used, as ratios (e.g., 200mg/5mL vs 400mg/5mL) vary significantly.* ## Dose Adjustments * **Renal Impairment (CrCl <30 mL/min):** Use is generally not recommended for the 875 mg strength. Formulations must be adjusted based on the specific eGFR/CrCl; systemic accumulation of clavulanate is a concern. * **Hepatic Impairment:** Use with caution; monitor hepatic function frequently. ## Contraindications * History of cholestatic jaundice or hepatic dysfunction associated with amoxicillin/clavulanate therapy. * Known serious hypersensitivity (e.g., anaphylaxis, Stevens-Johnson syndrome) to amoxicillin, clavulanate, or other beta-lactams (penicillins/cephalosporins). ## Adverse Effects * **Common:** Diarrhea (frequently associated with the clavulanate component), nausea, vomiting, and candidiasis (oral/vaginal). * **Serious:** Cholestatic jaundice, severe cutaneous adverse reactions (SCARs), Clostridioides difficile-associated diarrhea (CDAD), and anaphylaxis. ## Key Drug Interactions * **Warfarin:** May increase the anticoagulant effect (monitor INR/PT). * **Methotrexate:** May decrease clearance, increasing the risk of toxicity. * **Probenecid:** Decreases renal tubular secretion of amoxicillin, increasing serum levels. * **Oral Contraceptives:** Potential for reduced efficacy (though evidence is limited, barrier methods are often recommended). ## Monitoring * Monitor periodic assessment of organ system functions (renal, hepatic, and hematopoietic) during prolonged therapy. * Monitor for signs of hypersensitivity reactions. * Observe for persistent watery/bloody diarrhea (risk of *C. difficile*). ## Clinical Pearls * **Administration:** Take with a meal or snack to minimize gastrointestinal upset. * **Formulation Warning:** The 250 mg tablet and the 250 mg chewable tablet should not be substituted for one another; they contain different amounts of clavulanicum and are not bioequivalent. * **Clavulanate-to-Amoxicillin Ratio:** Ensure the correct ratio is selected for the specific indication; excessive clavulanate can increase the risk of diarrhea. *** **Educational Disclaimer:** This information is for educational purposes only. Drug dosing, contraindications, and interaction profiles may change. Always verify current prescribing information, institutional protocols, and patient-specific factors with clinical decision support tools and official product monographs before prescribing or administering medication.